Brief: Immunovia Q2 Operating Loss SEK 20.1 Mln
28/08/2025 07:49
Aug 28 (Reuters) - Immunovia AB (publ) IMMNOV.ST: Q2 NET SALES 90 KSEK (85) Q2 OPERATING LOSS WAS -20.1 MSEK Source text: ID:nMFNP6YxS Further company coverage: IMMNOV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study